Recurrent C. diff infection is when you contract a C. diff infection 2 to 8 weeks after completing treatment for a previous one. C. diff relapse is a recurrence of the same strain, while reinfection ...

The highly contagious Clostridium difficil spreads more than three times as much within intensive care unit environments as previously recognized, according to a study published April 3 in JAMA ...

Add Yahoo as a preferred source to see more of our stories on Google. Clostridiumdifficile infection (also known as C. diff or CDI) is one of the most common hospital-acquired infections and is a ...

A new study found a 45% reduction in C. diff infections among high-risk patients when the antibiotic doxycycline was used instead of azithromycin. Photo by cottonbro studio/Pexels A new study on ...

Most cases of C. diff are treated with oral antibiotics that specifically target the infection, such as vancomycin or fidaxomicin. These medications work by eliminating the C. diff bacteria while ...

A novel vaccination approach developed by Vanderbilt Health researchers cleared the harmful gut bacterium Clostridioides difficile (C. diff) in an animal model of infection. An experimental vaccine ...

The antibiotic vancomycin, recommended as first-line treatment for infection caused by the deadly superbug C. difficile (C. diff), may not be living up to its promise, according to new research. The ...

Newly discovered iron storage 'ferrosomes' inside the bacterium C. diff -- the leading cause of hospital-acquired infections -- are important for infection in an animal model and could offer new ...

DEAR DR. ROACH: About one year ago, I had Clostridioides difficile (C. diff) that was treated with 125 mg of vancomycin for about four weeks. I had none of the usual risk factors, and the cause was ...

A new study on Clostridioides difficile infections finds that choosing an alternative antibiotic for high-risk patients with pneumonia can reduce infection risk. C. diff infections can be deadly, and ...

Iron storage “spheres” inside the bacterium C. diff — the leading cause of hospital-acquired infections — could offer new targets for antibacterial drugs to combat the pathogen. A team of Vanderbilt ...